Katz Barrett

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-01-18	2023-01-17	Viridian Therapeutics Inc (VRDN)	PlS Planned sale	23,425 +10.0% 165.50 US$110,408	23,425 +10.0%	165.50	US$110,408
2023-01-18	2023-01-13	Viridian Therapeutics Inc (VRDN)	PlS Planned sale	60,810 +44.0% 36.04 US$3,075,617	60,810 +44.0%	36.04	US$3,075,617
2023-01-11	2023-01-10	Viridian Therapeutics Inc (VRDN)	PlS Planned sale	89,205 -28.5% 320.45 US$2,286,792	89,205 -28.5%	320.45	US$2,286,792
2023-01-11	2023-01-09	Viridian Therapeutics Inc (VRDN)	PlS Planned sale	12,623 -100.0% 33.04 US$417,064	12,623 -100.0%	33.04	US$417,064